Literature DB >> 11836633

Role of estrogen receptor in the regulation of estrogen induced amino acid transport of System A in breast cancer and other receptor positive tumor cells.

Hari K Bhat1, Jaydutt V Vadgama.   

Abstract

The transport of amino acids across the plasma membrane is a process of fundamental physiological importance. If this process is modified by estrogens and if estrogen receptors play a role in this regulation, then the alteration of metabolic events will be of significant importance in cancer cells which have high estrogen receptor content because estrogens modify cellular physiology through transactivational effects of their cognate receptors. In the present study, we investigated the role of 17 beta-estradiol on the regulation of different amino acid transport systems, in particular, Systems A, ASC and y+ in estrogen receptor positive (MCF-7, T47D, H-301) and estrogen receptor negative (MCF-10, SKBR-3, MDA-MB-231) cell lines. The cells were treated with 17 beta-estradiol (10 nM), ICI 182780 (1 microM), or 17 beta-estradiol plus ICI 182780. We discovered that 17 beta-estradiol specifically stimulates System A activity by 2- to 4-fold in estrogen receptor positive cell lines with a maximal stimulation 48 h after estrogen-treatment while no stimulation was observed in estrogen receptor negative cell lines. Estrogen-dependent activation of System A was inhibited by co-treatment with the antiestrogen ICI 182780. Northern blot analysis showed that System A mRNA levels are also increased following estrogen treatment, and this induction of mRNA transcript levels by estrogen can be inhibited by co-treatment with antiestrogen ICI 182780. The increase in System A transport activity following estrogen treatment was abbrogated when estrogen receptor positive cells were stably transfected with human antisense ER alpha cDNA. Kinetic analysis demonstrated that estrogen-induced stimulation results in a doubling of Vmax with no changes in Km. However, 17 beta-estradiol did not stimulate the activation of transport systems responsible for the transport of arginine (y+) or threonine (ASC). In summary, we have provided evidence that estrogen receptors play a role in the activation of System A by estrogen. This adaptation may have important physiological and nutritional significance on estrogen dependent growth of breast tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836633

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

1.  shRNA-mediated Slc38a1 silencing inhibits migration, but not invasiveness of human pancreatic cancer cells.

Authors:  Jing Xie; Zhen Chen; Luming Liu; Ping Li; Xiaoyan Zhu; Huifeng Gao; Zhiqiang Meng
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 2.  Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family.

Authors:  Bryan Mackenzie; Jeffrey D Erickson
Journal:  Pflugers Arch       Date:  2003-07-04       Impact factor: 3.657

3.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

4.  Transcriptional regulation of the sodium-coupled neutral amino acid transporter (SNAT2) by 17β-estradiol.

Authors:  Laura A Velázquez-Villegas; Víctor Ortíz; Anders Ström; Nimbe Torres; David A Engler; Risë Matsunami; David Ordaz-Rosado; Rocío García-Becerra; Adriana M López-Barradas; Fernando Larrea; Jan-Åke Gustafsson; Armando R Tovar
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-23       Impact factor: 11.205

5.  Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Leigh Murphy; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  J Steroid Biochem Mol Biol       Date:  2014-09-19       Impact factor: 4.292

6.  Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer.

Authors:  Jing Xie; Ping Li; Hui-Feng Gao; Jian-Xin Qian; Ling-Yan Yuan; Jie-Jun Wang
Journal:  BMC Gastroenterol       Date:  2014-04-09       Impact factor: 3.067

7.  Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.

Authors:  Matteo Morotti; Esther Bridges; Alessandro Valli; Hani Choudhry; Helen Sheldon; Simon Wigfield; Nicki Gray; Christos E Zois; Fiona Grimm; Dylan Jones; Eugene J Teoh; Wei-Chen Cheng; Simon Lord; Dimitrios Anastasiou; Syed Haider; Alan McIntyre; Deborah C I Goberdhan; Francesca Buffa; Adrian L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-31       Impact factor: 11.205

8.  Estrogen regulation and ion dependence of taurine uptake by MCF-7 human breast cancer cells.

Authors:  David B Shennan; Jean Thomson
Journal:  Cell Mol Biol Lett       Date:  2007-03-03       Impact factor: 5.787

9.  Lysine in Combination With Estradiol Promote Dissemination of Estrogen Receptor Positive Breast Cancer via Upregulation of U2AF1 and RPN2 Proteins.

Authors:  Gabriela Vazquez Rodriguez; Annelie Abrahamsson; Maria V Turkina; Charlotta Dabrosin
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

10.  SLC38A2 provides proline and alanine to regulate postnatal bone mass accrual in mice.

Authors:  Leyao Shen; Yilin Yu; Courtney M Karner
Journal:  Front Physiol       Date:  2022-09-23       Impact factor: 4.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.